Chemoembolization and radioembolization for hepatocellular carcinoma.
about
Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinomaMinimally invasive local therapies for liver cancerLocally ablative therapies for primary and metastatic liver cancer.Development of biodegradable radiopaque microsphere for arterial embolization-a pig studyYttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.Imaging, biodistribution and efficacy evaluation of 188Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model.Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study.HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENT.Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.[Primary liver tumors. Preoperative conditioning of the liver and perioperative management in extended liver resection].Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.Biodistribution, Pharmacokinetics and Efficacy of 188Re(I)-Tricarbonyl-Labeled Human Serum Albumin Microspheres in an Orthotopic Hepatoma Rat Model.
P2860
Q26766707-C278827E-7BD9-414B-A5AE-AE874021388DQ34974386-788F14F1-CF41-4D45-A2DA-5D59B03DCF75Q35152457-98ABA5F4-4668-43EF-BB9B-72FA5F256EB1Q36006427-6A2E0884-3EE9-4936-9624-D439B81AD463Q36268905-7B0F78F0-DA28-4002-8787-3D27BF61E01BQ37483200-E41D5051-ACF6-4FB9-AEF6-566B6126E4CAQ38652404-3CD27EF5-AA69-408E-999E-B9792EE8BFB4Q38723174-F6B0FCBF-01D3-437E-8723-A95FAEFE4924Q38820543-CDDED1D5-E55C-4AEF-A949-BBB1F31D56E4Q45922623-4CD022FD-27F9-4053-886E-58A779B3CB71Q47552666-5EBE331D-F939-492F-B919-97A8C673C8DAQ47724444-9031C389-CC7E-44F8-B7F5-DCDAE137F389Q51063349-9BBB9ABB-1EF1-434E-8571-F6C369DE8416Q53611929-D8D37C39-C631-42BE-A7AA-FBE94535A4AEQ55312644-607745E0-1AFD-4378-B00A-70A7BE05279FQ55504888-DF249C43-C0C0-4712-9A86-4ACE197094B8
P2860
Chemoembolization and radioembolization for hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemoembolization and radioembolization for hepatocellular carcinoma.
@en
Chemoembolization and radioembolization for hepatocellular carcinoma.
@nl
type
label
Chemoembolization and radioembolization for hepatocellular carcinoma.
@en
Chemoembolization and radioembolization for hepatocellular carcinoma.
@nl
prefLabel
Chemoembolization and radioembolization for hepatocellular carcinoma.
@en
Chemoembolization and radioembolization for hepatocellular carcinoma.
@nl
P2860
P1476
Chemoembolization and radioembolization for hepatocellular carcinoma
@en
P2093
Robert J Lewandowski
P2860
P304
604-11; quiz e43-4
P356
10.1016/J.CGH.2012.12.039
P407
P50
P577
2013-01-26T00:00:00Z